- Home
- ARVN vs CMRE Comparison
ARVN vs CMRE Comparison
Compare ARVN & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | CMRE |
|---|---|---|
| Founded | 2015 | 1974 |
| Country | United States | Monaco |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.0M | 1.8B |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ARVN | CMRE |
|---|---|---|
| Price | $12.58 | $15.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 23 | 1 |
| Target Price | ★ $17.80 | $12.00 |
| AVG Volume (30 Days) | ★ 2.3M | 492.3K |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.51 |
| Revenue | $312,300,000.00 | ★ $2,085,335,000.00 |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.25 |
| Revenue Growth | ★ 93.86 | 79.87 |
| 52 Week Low | $5.90 | $6.63 |
| 52 Week High | $22.48 | $16.40 |
Technical Indicators
Market Signals| Indicator | ARVN | CMRE |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 61.39 |
| Support Level | $12.47 | $15.48 |
| Resistance Level | $13.56 | $16.19 |
| Average True Range (ATR) | 0.53 | 0.34 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 50.68 | 38.97 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.